{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T17:11:08Z","timestamp":1782234668401,"version":"3.54.5"},"reference-count":10,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,8,22]]},"DOI":"10.7759\/cureus.1594","type":"journal-article","created":{"date-parts":[[2024,2,23]],"date-time":"2024-02-23T12:09:59Z","timestamp":1708690199000},"source":"Crossref","is-referenced-by-count":6,"title":["Ifosfamide-Induced Malignancy of Ureter and Bladder"],"prefix":"10.7759","author":[{"given":"Aparna","family":"Sannu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Resmi","family":"Radha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anitha","family":"Mathews","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rari","family":"Padmakumari Mony","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anil","family":"Prahladan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francis V","family":"James","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","unstructured":"Highlights of prescribing information \u2013 Ifex. FDA. (2012). Accessed. 3rd June 2017: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2012\/019763s017lbl.pdf."},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/0006-2952(79)90222-3","article-title":"Cyclophosphamide cystitis\u2014identification of acrolein as the causative agent","volume":"28","author":"Cox PJ","year":"1979","unstructured":"Cox PJ. Cyclophosphamide cystitis\u2014identification of acrolein as the causative agent. Biochem Pharmacol. 1979, 28:2045\u20132049. 10.1016\/0006-2952(79)90222-3","journal-title":"Biochem Pharmacol"},{"key":"ref3","article-title":"Second malignant neoplasms among long-term survivors of ovarian cancer","volume":"56","author":"Travis LB","year":"1996","unstructured":"Travis LB, Curtis RE, Boice JD, Platz CE, Hankey BF, Fraumeni JF Jr. Second malignant neoplasms among long-term survivors of ovarian cancer. Cancer Res. 1996, 56:1564\u20131570.","journal-title":"Cancer Res"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/87.7.524","article-title":"Bladder and kidney cancer following cyclophosphamide therapy for non-Hodgkin's lymphoma","volume":"87","author":"Travis LB","year":"1995","unstructured":"Travis LB, Curtis RE, Glimelius B, et al..  Bladder and kidney cancer following cyclophosphamide therapy for non-Hodgkin's lymphoma. J Natl Cancer Inst. 1995, 87:524\u2013531. 10.1093\/jnci\/87.7.524","journal-title":"J Natl Cancer Inst"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(87)90490-6","article-title":"Malignancy following treatment of rheumatoid arthritis with cyclophosphamide: long-term case-control follow-up study","volume":"83","author":"Baker GL","year":"1987","unstructured":"Baker GL, Kahl LE, Zee BC, Stolzer BL, Agarwal AK, Medsger TA Jr. Malignancy following treatment of rheumatoid arthritis with cyclophosphamide: long-term case-control follow-up study. Am J Med. 1987, 83:1\u20139. 10.1016\/0002-9343(87)90490-6","journal-title":"Am J Med"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.3.5767.182-a","article-title":"Cyclophosphamide and the bladder","volume":"3","author":"Worth PH","year":"1971","unstructured":"Worth PH. Cyclophosphamide and the bladder. Br Med J. 1971, 3:182. 10.1136\/bmj.3.5767.182-a","journal-title":"Br Med J"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.2910630102","article-title":"Bladder tumours following chemotherapy and radiotherapy for ovarian cancer: a case-control study","volume":"63","author":"Kaldor JM","year":"1995","unstructured":"Kaldor JM, Day NE, Kittelmann B, et al.. Bladder tumours following chemotherapy and radiotherapy for ovarian cancer: a case-control study. Int J Cancer. 1995, 63:1\u20136. 10.1002\/ijc.2910630102","journal-title":"Int J Cancer"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1097\/01.mph.0000243664.02174.73","article-title":"Second malignant neoplasm in patients with osteosarcoma of the extremities treated with adjuvant and neoadjuvant chemotherapy","volume":"28","author":"Bacci G","year":"2006","unstructured":"Bacci G, Ferrari C, Longhi A, et al.. Second malignant neoplasm in patients with osteosarcoma of the extremities treated with adjuvant and neoadjuvant chemotherapy. J Pediatr Hematol Oncol. 2006, 28:774\u2013780. 10.1097\/01.mph.0000243664.02174.73","journal-title":"J Pediatr Hematol Oncol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.27493","article-title":"Late effects of chemotherapy and radiotherapy in osteosarcoma and Ewing sarcoma patients","volume":"118","author":"Longhi A","year":"2012","unstructured":"Longhi A, Ferrari S, Tamburini A, Luksch R, Fagioli F, Bacci G, Ferrari C. Late effects of chemotherapy and radiotherapy in osteosarcoma and Ewing sarcoma patients. Cancer. 2012, 118:5050\u20135059. 10.1002\/cncr.27493","journal-title":"Cancer"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-014-4070-2","article-title":"Secondary malignant neoplasms after osteosarcoma: early onset and cumulative alkylating agent dose dependency","volume":"22","author":"Kim SH","year":"2015","unstructured":"Kim SH, Shin KH, Seok SO, Cho YJ, Noh JK, Suh JS, Yang WI. Secondary malignant neoplasms after osteosarcoma: early onset and cumulative alkylating agent dose dependency. Ann Surg Oncol. 2015, 22:859\u2013865. 10.1245\/s10434-014-4070-2","journal-title":"Ann Surg Oncol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/6973-ifosfamide-induced-malignancy-of-ureter-and-bladder","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,23]],"date-time":"2024-02-23T12:10:02Z","timestamp":1708690202000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/6973-ifosfamide-induced-malignancy-of-ureter-and-bladder"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8,22]]},"references-count":10,"URL":"https:\/\/doi.org\/10.7759\/cureus.1594","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2017,8,22]]}}}